Department of Emergency Medicine, Health Science University Antalya Training and Research Hospital, Antalya, Turkey.
Department of Emergency Medicine, Health Science University Antalya Training and Research Hospital, Antalya, Turkey.
Int Immunopharmacol. 2021 Jan;90:107154. doi: 10.1016/j.intimp.2020.107154. Epub 2020 Nov 21.
We have read the article by Yang et al, entitled "The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients" with great interest. The authors emphasized that the NLR (Neutrophil to lymphocyte ratio) is an independent prognostic biomarker for COVID-19 patients. First of all, we congratulate the authors for their valuable contribution to the literature in these difficult conditions. However, we would like to add on a few cases that need more attention.
我们饶有兴致地阅读了杨等作者撰写的题为“中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值在 COVID-19 患者中的诊断和预测作用”一文。作者强调,中性粒细胞与淋巴细胞比值(NLR)是 COVID-19 患者独立的预后生物标志物。首先,我们祝贺作者在这些困难条件下为文献做出了有价值的贡献。但是,我们想补充一些需要更多关注的情况。